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On a broad national basis. it should be quite
possible to substantially reduce maternal morbidity
and the disproportionately high numbers of perinatal
losses associated with diabetic pregnancies. Nation
wide, the overall perinatal mortality rate for this
group is approximately 20%. which is at least double
that incurred in centers where intensive care facilities
and personnel are available. and consistent, well
coordinated care by the health team is provided.
Although the prognosis for fetal survival is less
favorable with advances in severity of the diabetic
state. there is a significant risk even during the
mildest stage of the disease. Careful prospective
studies. notably those of O'Sullivan and his group.
have demonstrated that gestational diabetics have a
higher than normal perinatal mortality. Prevention
begins with diagnosis.
Detection. Ideally, a two-hour postprandial
screening of blood sugar following a 100 g
carbohydrate-equivalent breakfast should be a stan
dard prenatal laboratory test. In practicality. all
patients with a poor obstetric history, previous
perinatal losses, large babies, a family history of
diabetes. glycosuria, or significant obesity are can
didates for a glucose tolerance test. Using these
criteria, we subjected 3,340 prenatal patients to the
three-hour glucose tolerance test following a 100 g
glucose load, and 540 showed abnormal responses.
The yield of positives, therefore, was I in 6.3 suspects,
and the overall incidence of gestational diabetes in
this Philadelphia population was 1.18%. Criteria used
are as follows: fasting = 90 mg %: I hour = 165 mg
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%: 2 hour = 145 mg %: 3 hour = 125 mg%. Glucose
tolerance is impaired if two or more of these values
are equaled or exceeded. The test is performed on
whole blood using the Somogyi method or
autoanalyzer (Hoffman) method. If plasma or serum
is used. 10 mg % should be added to each of the
values. The importance of a very large screening
program was shown in the prospective study con
ducted by O'Sullivan and his group who found that
screening is particularly important in the obese,
older-age patient. Perinatal mortality was 1.5% for
normal control patients and 6.4% for those with
gestational diabetes. The increase in perinatal loss
was strikingly evident in gestational diabetic mothers
25 years of age or older, with the risk further in
creased by obesity.
Metabolic Control. How strict should this be'1
These patients are ketosis prone. Ketosis is one of the
most lethal events for the fetus. but one of the most
preventable complications for the mother. The in
cidence of intrauterine fetal death is greatly increased
in pregnancies complicated by pre-coma maternal
acidosis. Of further concern is the fact that the
National Collaborative Study reveals a significant
relationship between maternal ketonuria and central
nervous system defects or deficiencies in the off
spring. Neither insulin treatment nor hypoglycemia
shows a positive association. For these reasons the
patient should be kept as nearly normoglycemic as
possible and free of ketonuria even at the expense
of an occasional episode of hypoglycemia which is
readily controlled.
Many, but not all, gestational diabetics can be
maintained on diet alone. The response to diet is
determined on the basis of a two-hour postprandial
blood sugar obtained at two-week intervals. If the
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two-hour value on diet cannot be maintained below
160 mg%, the patient needs insulin, and for the pur
pose of management of the pregnancy such patients
should be considered in the insulin-dependent cate
gory.
Is there any advantage in treating all gestational
diabetics with low-dose insulin? Several groups in this
country and abroad have compared treated and un
treated cases. Apart from slight reduction in over
sized infants, other advantages are not yet sufficiently
clear-cut to warrant recommending this approach.
Oral hypoglycemic agents should not be used in
pregnancy. In contrast to insulin, the sulfonyl ureas
pass the placental barrier readily. Neonatal hepatic
function is relatively immature, and the newborn
metabolizes these drugs poorly. Intractable
hypoglycemia persisting as long as the eleventh day
of life, and in some instances requiring exchange
transfusion, have been reported, particularly in rela
tion to long-acting preparations such as chlor
propamide. The biguanides which raise the blood lac
tate level may accentuate the tendency to maternal
ketoacidosis and are contraindicated during pregnan
cy.
The anti-insulin effects of pregnancy usually
cause significant changes in insulin needs after the
20 th week of gestation. The rise in requirement is
sometimes precipitous about the 24th to 26th week.
Both the patient and the physician should be on the
lookout for these changes. In our patients, 75% needed
a mean of about 60% more insulin. Twenty-three
percent showed only minor increase in insulin
requirement. Only an occasional patient showed
reduction in insulin need.
One of the poorly understood problems has to
do with remission, which may occur particularly in
the early stages of diabetes. How does one handle the
patient who states that she had an abnormal glucose
tolerance test with her previous pregnancy and was
treated accordingly, but the glucose tolerance test in
the present pregnancy is normal? While it is the rule
that the diabetic state will progress, remissions do oc
cur. We have encountered this phenomenon in a
number of gestational diabetics and in one case of
f
juvenile diabetes. Since the adverse ef ect upon the
fetus can occur al any stage including the prediabetic
period, it is important to accept the reality of remis
sion and to avoid the temptation to ascribe its oc
currence to faulty initial diagnosis.
Most diabetics have some degree of hydramnios,
excessive in approximately 10% of cases. The com-

mon practice of prophylactic use of diuretic and
rigid salt restriction may do more harm than good.
Thiazides are useful only in otherwise uncompli
cated fluid retention. If administered alternately
three days on and three days off, these drugs will
often reverse simple fluid shifts without disturbing
electrolyte balance, but they are ineffectual for re
versal of toxemia or hydramnios. Hospitalization
is necessary if these conditions develop. Asympto
matic bacteriuria is found in about 12 or 13% of
diabetic pregnancies, or approximately twice the
overall incidence, and should be treated when
found.
Prenatal Monitoring. The ability to predict in
trauterine fetal deaths in diabetic pregnancies on
clinical evidence alone has limitations. A reliable
method for assessing intrauterine fetal welfare should
be available in every diabetic pregnancy. Although
no single test is capable of detecting all types of
malfunctions that affect the fetus, the urine estriol
test is, in our experience, indispensable. The fact
that estriol production requires a fetal as well as a
placental component is an obvious advantage. The
types of cases in which estriol values may be mis
leading are small in number and can usually be
readily identified. These are mainly cases in which
renal function is markedly reduced and renal clear
ance of estriol diminished.
Although the majority of patients with mild
diabetes can be maintained free of complications and
await labor at term, some cannot. Fetal deaths do oc
cur in the virtually asymptomatic, well-controlled
gestational diabetic pregnancy. In these cases, estriol
determinations have proved to be of great value in
identifying the fetus in jeopardy who should be
delivered and, on the other hand, in providing
reassurance and safe conduct through the natural
course of pregnancy when estriol values remain in the
normal range.
Recent recommendations have been made to
apply the same principles to pregnancies complicated
by overt diabetes. While it is feasible to individualize
and extend the timing of delivery to the 38th week
or even beyond in many cases of B and C insulin
dependent diabetics, those with advanced disease are
poor candidates for this approach, even with frequent
monitoring. From a practical point of view, and
purely on clinical grounds, pregnancy in a patient
with angiopathy, retinopathy, or nephropathy can
rarely be carried beyond the 37th week, and all too
often the pregnancy has to be terminated before that
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optimal time in the interest of the mother or baby or
both. The suddenness with which serious changes or
events can take place in these patients and the fact
that methods for determining fetal maturity are
available (particularly the lecithin/sphingomyelin
ratio and the creatinine concentration) offset the
possible advantages of attempting to extend the
gestational period for Classes D. E. and F diabetics
beyond 37 weeks.
The infant of a diabetic mother is at risk from
the moment of birth. Respiratory distress is the
greatest threat. It is most directly related to
prematurity and accentuated in diabetes. While tests
for fetal maturity should make iatrogenic prematuri
ty preventable, early delivery will continue to be
necessary in selected cases to avoid intrauterine fetal
death or damage. The neonatologist experienced in
dealing with respiratory pathophysiology who can
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initiate treatment within minutes after birth, and a
neonatal intensive care unit capable of providing
clinical and laboratory support services on a 24hour-a-day basis offer the best chance for intact
survival.
In principle. the problems of diabetic pregnan
cies do not differ from the problems of at least two
thirds of all high-risk pregnancies, and in this respect,
they serve as a prototype for centralized perinatal
care. The demands in terms of medical and
paramedical manpower. the high cost of services and
facilities comprising the perinatal center, and the con
cern for quality of life will surely require revision of
the current health care delivery system. Consolida
tion of scarce resources in centers. whether teaching
or community hospitals. capable of providing
specialized care for the high-risk mother and new
born is the logical approach.

